slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 87,721-87,750
Pages 3,225
Rows per page 30
Component
87,721-87,750 of 96,741
04
The slide uses a process-oriented layout to define the industry landscape.AbCellera | Investor Presentation Deck | 20 slides · AbCellera
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a green callout box to emphasize the deal structure.AbCellera | Investor Presentation Deck | 20 slides · AbCellera
Pitch deck Investor relations Beat · Business Model1 hit
06
The slide features a scientific poster as an embedded image, which contains multiple charts and technical data points.AbCellera | Results Presentation Deck | 18 slides · AbCellera
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
07
The slide features a thumbnail of a scientific poster titled 'Breaking barriers to access intracellular targets with T-cell engagers'.AbCellera | Results Presentation Deck | 18 slides · AbCellera
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a dark overlay on a photo of people working, with a prominent callout box for the key achievement.AbCellera | Results Presentation Deck | 18 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
09
The slide uses a dark overlay on a professional photo to emphasize the text.AbCellera | Results Presentation Deck | 18 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
05
The chart shows a multi-year trend of in-store sampling events, with a specific callout for +27% YOY growth.Advantage Solutions | Results Presentation Deck | 13 slides · Advantage Solutions
Conference presentation Investor relations Beat · EvidenceLoop · Logic Chain1 hit
06
Includes a visual representation of debt maturity and a callout regarding interest rate hedging.Advantage Solutions | Results Presentation Deck | 13 slides · Advantage Solutions
Conference presentation Investor relations Beat · EvidenceLoop · Logic Chain1 hit
07
Includes testimonials from KOLs to emphasize the difficulty of patient compliance.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
10
The slide outlines a multi-part clinical trial design with specific dosing cohorts and eligibility requirements.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution Approach1 hit
12
Aeglea BioTherapeutics | Investor Presentation Deck | 38 slidesAeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
13
ADA stands for Anti-Drug Antibodies.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses a timeline-based progression of symptoms to illustrate the severity of the disease.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
17
Includes box plots for arginine levels and bar charts for patient normalization rates.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
18
Clinical trial data presentation with statistical significance markers and MCID thresholds.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
19
The slide uses a heatmap to display individual patient outcomes across four metrics (pArg, GMFM-E, 2MWT, GMFM-D).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
20
The slide presents clinical trial safety data comparing Pegzilarginase to a placebo group.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
25
The slide uses a biological pathway diagram to explain the mechanism of action of the drug candidate.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · TractionLoop · Before After1 hit
05
Allbirds | Investor Presentation Deck | 13 slidesAllbirds | Investor Presentation Deck | 13 slides · Allbirds
Conference presentation Investor relations Loop · Why Now1 hit
08
The slide uses a waterfall-like progression to show growth from existing to pipeline.Allego | Results Presentation Deck | 17 slides · Allego
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
06
Includes a 'click to learn more' interactive element, likely from a digital presentation deck.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
09
The slide uses a color-coded column layout to present performance metrics for different investment strategies.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
20
The slide uses a three-column layout to highlight key value propositions.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
22
Includes a disclaimer at the bottom regarding an FDA clinical hold.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
23
The slide uses two distinct chart types (dose-response curve and bar chart) to show efficacy in two different biological assays.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
25
The slide uses a biological map of the coronavirus genome to justify targeting nsp5 and nsp12.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
26
The slide highlights key therapeutic advantages of the candidate drug.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
09
The table includes a breakdown of expense categories and a variance analysis (B/(W)).Synchrony Financial | Results Presentation Deck | 16 slides · Synchrony
Conference presentation Investor relations 1 hit
13
The slide uses a stacked bar chart to differentiate between 'Thrift and Donation' and 'Resale' segments, with a callout for supply-side waste metrics.thredUP | Investor Presentation Deck | 33 slides · thredUP
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
10
The chart uses a break in the Y-axis to accommodate the large starting and ending values relative to the smaller variance bars.UBS | Results Presentation Deck | 28 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit